Edition:
United States

Mazor Robotics Ltd (MZOR.OQ)

MZOR.OQ on NASDAQ Stock Exchange Global Market

53.04USD
8 Dec 2017
Change (% chg)

$-0.68 (-1.27%)
Prev Close
$53.72
Open
$54.31
Day's High
$55.38
Day's Low
$52.97
Volume
60,991
Avg. Vol
142,931
52-wk High
$65.97
52-wk Low
$20.51

Chart for

About

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $1,387.95
Shares Outstanding(Mil.): 25.94
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.09 15.67
EPS (TTM): -- -- --
ROI: -- 9.98 34.62
ROE: -- 15.22 16.00

BRIEF-Mazor Robotics Gets Permission To Disclose Subject Of May Investigation

* SAYS ISRAELI SECURITIES AUTHORITY GAVE PERMISSION TO DISCLOSE SUBJECT OF MAY 2017 INVESTIGATION RELATES TO INSIDER TRADING BY THIRD PARTIES

Dec 05 2017

BRIEF-Mazor Robotics received 22 system orders during Q3 2017

* Mazor Robotics received 22 system orders during Q3 2017; expects to report record quarterly revenue

Oct 09 2017

BRIEF-Mazor Robotics says Medtronic to make $40 million third tranche investment in Mazor

* Mazor Robotics and Medtronic enter next phase of strategic partnership; Medtronic to make a $40 million third tranche investment in Mazor

Aug 30 2017

BRIEF-Menora Mivtachim Holdings reports 5.38 pct passive stake in Mazor Robotics

* Menora Mivtachim Holdings Ltd reports a 5.38 pct passive stake in Mazor Robotics Ltd as of July 24 - SEC filing Source text: (http://bit.ly/2f1p1Mj)

Jul 31 2017

Israel's Mazor Robotics sees record Q2 revenue

* Mazor Robotics, an Israeli maker of guidance systems for spine and brain surgeries, said on Thursday it expects to report record revenue of $15.4 million for the second quarter, up from $8.3 million a year earlier.

Jul 06 2017

Earnings vs. Estimates